Exponent sees FY25 revenue before reimbursements up in the low single digits

For the full fiscal year 2025 as compared to fiscal year 2024, Exponent (EXPO) anticipates: Revenues before reimbursements to grow in the low single digits; and, EBITDA1 to be 26.50% to 27.0% of revenues before reimbursements. “We are encouraged by the market opportunities across the industries that we serve, and our recruiting activity is driving increases in headcount as we strategically build upon our diversified portfolio of talent and capabilities,” commented Richard Schlenker, Executive Vice President and Chief Financial Officer. “Based on current market demand, we continue to expect growth in the second half of 2025 and are maintaining our full year guidance.”